Perlecan-rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor

Journal of Oral Pathology and Medicine

Volumn 37, Issue 5, 2008, Pages 287-293

  Tsuneki, Masayuki ^a   Cheng, Jun ^a   Maruyama, Satoshi ^a   Ida Yonemochi, Hiroko ^a   Nakajima, Motowo ^b   Saku, Takashi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Tsukuba Research Institute   (Japan)

Author keywords

Cystic lining epithelium; Intraepithelial stroma; Keratocystic odontogenic tumor; Ki 67 labeling index; Perlecan

Indexed keywords

HEPARAN SULFATE; HEPARANASE; KI 67 ANTIGEN; MESSENGER RNA; PERLECAN; PROTEOGLYCAN;

ARTICLE; BASEMENT MEMBRANE; CELL LABELING; CELL PROLIFERATION; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUTH CARCINOMA; ODONTOGENIC TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; SALIVARY GLAND TUMOR; SIGNAL TRANSDUCTION;

CELL PROLIFERATION; EPITHELIAL CELLS; GENE EXPRESSION; GLUCURONIDASE; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; JAW NEOPLASMS; KI-67 ANTIGEN; ODONTOGENIC CYSTS; ODONTOGENIC TUMORS; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 42149168084     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00620.x     Document Type: Article

References (44)

1. Ida-Yonemochi H, Saku T. Perlecan, a heparan sulfate proteoglycan, is a major constituent of the intraepithelial stroma functioning in tooth morphogenesis. J Oral Biosci 2006 48 : 233 43.
2. Farach-Carson MC, Carson DD. Perlecan: a multifunctional extracellular proteoglycan scaffold. Glycobiology 2007. (Epub ahead of print, PMID: 17442708).
3. Knox SM, Whitelock JM. Perlecan: how does one molecule do so many things? Cell Mol Life Sci 2006 63 : 2435 45.
4. Iozzo RV. Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol 2005 6 : 646 56.
5. Saku T, Cheng J, Okabe H, Koyama Z. Immunolocalization of basement membrane molecules in the stroma of salivary gland pleomorphic adenoma. J Oral Pathol Med 1990 19 : 208 14.
6. Cheng J, Saku T, Okabe H, Furthmayr H. Basement membranes in adenoid cystic carcinoma. An immunohistochemical study. Cancer 1992 69 : 2631 40.
7. Ida-Yonemochi H, Ikarashi T, Nagata M, Hoshina H, Takagi R, Saku T. The basement membrane-type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture. Virchows Arch 2002 441 : 165 73.
8. Ida-Yonemochi H, Ohshiro K, Swelam W, Metwaly H, Saku T. Perlecan, a basement membrane-type heparan sulfate proteoglycan, in the enamel organ: its intraepithelial localization in the stellate reticulum. J Histochem Cytochem 2005 53 : 763 772.
9. Ikarashi T, Ida-Yonemochi H, Ohshiro K, Cheng J, Saku T. Intraepithelial expression of perlecan, a basement membrane-type heparan sulfate proteoglycan reflects dysplastic changes of the oral mucosal epithelium. J Oral Pathol Med 2004 33 : 87 95.
10. Kimura S, Cheng J, Toyoshima K, Oda K, Saku T. Basement membrane heparan sulfate proteoglycan (Perlecan) synthesized by ACC3, adenoid cystic carcinoma cells of human salivary gland origin. J Biochem 1999 125 : 406 13.
11. Philipsen HP. Om Keratocyster (kolesteatoma) I Kaeberbe. Tandlaegebladet 1956 60 : 963 80.
12. Myoung H, Hong SP, Hong SD, et al. Odontogenic keratocyst: review of 256 cases for recurrence and clinicopathologic parameters. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 91 : 328 33.
13. Vedtofte P, Praetorius F. Recurrence of the odontogenic keratocyst in relation to clinical and histological features. A 20-year follow-up study of 72 patients. Int J Oral Surg 1979 8 : 412 20.
14. Partridge M, Towers JF. The primordial cyst (odontogenic keratocyst): its tumour-like characteristics and behaviour. Br J Oral Maxillofac Surg 1987 25 : 271 9.
15. Anand VK, Arrowood JP Jr., Krolls SO. Malignant potential of the odontogenic keratocyst. Otolaryngol Head Neck Surg 1994 111 : 124 9.
16. Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour. Oral Oncol 2002 38 : 219 26.
17. Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 3. Immunocytochemistry of cytokeratin and other epithelial cell markers. Oral Oncol 2002 38 : 407 15.
18. Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies. Oral Oncol 2002 38 : 323 31 (Erratum in: Oral Oncol 2004; 40: 107).
19. Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996 85 : 841 51.
20. Ohki K, Kumamoto H, Ichinohasama R, Sato T, Takahashi N, Ooya K. PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocyst. Int J Oral Maxillofac Surg 2004 33 : 584 92.
21. Lench NJ, High AS, Markham AF, Hume WJ, Robinson PA. Investigation of chromosome 9q22.3-q31 DNA marker loss in odontogenic keratocysts. Eur J Cancer B Oral Oncol 1996 32 : 202 6.
22. Gu XM, Zhao HS, Sun LS, Li TJ. PTCH mutations in sporadic and Gorlin-syndrome-related odontogenic keratocysts. J Dent Res 2006 85 : 859 63.
23. Philipsen HP. Keratocystic odontogenic tumour. In : Barnes L, Eveson JW, Reichart P, Sidransky D, eds Odontogenic tumours: keratocystic odontogenic tumour. Lyon : World Health Organization Classification of Tumors. Pathology and Genetics of Head and Neck Tumours. IARC Press, 2005 306 7.
24. Saku T, Furthmayr H. Characterization of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture: homology to the large molecular weight molecule of basement membranes. J Biol Chem 1989 264 : 3514 23.
25. Toyoshima M, Nakajima M. Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 1999 274 : 24153 60.
26. Makowski GJ, McGuff S, Van Sickels JE. Squamous cell carcinoma in a maxillary odontogenic keratocyst. J Oral Maxillofac Surg 2001 59 : 76 80.
27. De Paula AM, Carvalhais JN, Domingues MG, Barreto DC, Mesquita RA. Cell proliferation markers in the odontogenic keratocyst: effect of inflammation. J Oral Pathol Med 2000 29 : 477 82.
28. Matthews JB, Mason GI, Browne RM. Epithelial cell markers and proliferating cells in odontogenic jaw cysts. J Pathol 1988 156 : 283 90.
29. + cells within odontogenic jaw cyst epithelium. J Oral Pathol Med 1994 23 : 184 9.
30. Slootweg PJ. p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J Oral Pathol Med 1995 24 : 393 7.
31. Ogden GR, Chisholm DM, Kiddie RA, Lane DP. p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts. J Clin Pathol 1992 43 : 1007 10.
32. Agaram NNP, Collins BM, Barnes L, et al. Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch Pathol Lab Med 2004 128 : 313 7.
33. Levanat S, Gorlin RJ, Fallet S, Johnson DR, Fantasia JE, Bale AE. A two-hit model for developmental defects in Gorlin syndrome. Nat Genet 1996 12 : 85 7.
34. Zedan W, Robinson PA, High AS. A novel polymorphism in the PTC gene allows easy identification of allelic loss in basal cell nevus syndrome lesions. Diagn Mol Pathol 2001 10 : 41 5.
35. Matsuzawa N, Nagao T, Shimozato K, Niikawa N, Yoshiura KI. Patched homologue 1 mutations in four Japanese families with basal cell nevus syndrome. J Clin Pathol 2006 59 : 1084 6.
36. Clark P, Marker P, Bastian HL, Krogdahl A. Expression of p53, Ki-67, and EGFR in odontogenic keratocysts before and after decompression. J Oral Pathol Med 2006 35 : 568 72.
37. Working Committee on New Histopathological Criteria for Borderline Malignancies of the Oral Mucosa, Japanese Society for Oral Pathology. Guidelines for histopathological diagnosis of borderline malignancies of the oral mucosa: a preliminary proposal 2005. Niigata : Yamazaki Publishing Inc. Ltd, 2005.
38. Murata M, Cheng J, Horino M, Hara K, Shimokawa H, Saku T. Enamel proteins and extracellular matrix molecules are co-localized in the pseudocystic stromal space of adenomatoid odontogenic tumor. J Oral Pathol Med 2000 29 : 483 90.
39. Murdoch AD, Dodge GR, Cohen I, Tuan RS, Iozzo RV. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/Perlecan). J Biol Chem 1992 267 : 8544 57.
40. McKenzie EA. Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 2007 151 : 1 14.
41. Gotte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 2006 66 : 10233 7.
42. Nakajima M, Welch DR, Irimura T, Nicolson GL. Basement membrane degradative enzymes as possible markers of tumor metastasis. Prog Clin Biol Res 1986 212 : 113 22.
43. Mikami S, Ohashi K, Usui Y, et al. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn J Cancer Res 2001 92 : 1062 73.
44. Yamazaki M, Cheng J, Nomura T, Saito C, Hayashi T, Saku T. Maxillary odontogenic keratocyst with respiratory epithelium: a case report. J Oral Pathol Med 2003 32 : 496 8.